These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 14607557)

  • 1. Economic evaluation of highly purified menotropin compared with recombinant follicle-stimulating hormone in assisted reproduction.
    Lloyd A; Kennedy R; Hutchinson J; Sawyer W
    Fertil Steril; 2003 Nov; 80(5):1108-13. PubMed ID: 14607557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An economic evaluation of highly purified HMG and recombinant FSH based on a large randomized trial.
    Wechowski J; Connolly M; McEwan P; Kennedy R
    Reprod Biomed Online; 2007 Nov; 15(5):500-6. PubMed ID: 18028739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of highly purified human menopausal gonadotropin vs. recombinant follicle-stimulating hormone in first-cycle in vitro fertilization-intracytoplasmic sperm injection patients.
    Hompes PG; Broekmans FJ; Hoozemans DA; Schats R;
    Fertil Steril; 2008 Jun; 89(6):1685-93. PubMed ID: 17681325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Costs and outcomes associated with IVF using recombinant FSH.
    Ledger W; Wiebinga C; Anderson P; Irwin D; Holman A; Lloyd A
    Reprod Biomed Online; 2009 Sep; 19(3):337-42. PubMed ID: 19778478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-saving treatment strategies in in vitro fertilization: a combined economic evaluation of two large randomized clinical trials comparing highly purified human menopausal gonadotropin and recombinant follicle-stimulating hormone alpha.
    Wechowski J; Connolly M; Schneider D; McEwan P; Kennedy R
    Fertil Steril; 2009 Apr; 91(4):1067-76. PubMed ID: 18339384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic Evaluation of Three Frequently Used Gonadotrophins in Assisted Reproduction Techniques in the Management of Infertility in the Netherlands.
    Fragoulakis V; Pescott CP; Smeenk JM; van Santbrink EJ; Oosterhuis GJ; Broekmans FJ; Maniadakis N
    Appl Health Econ Health Policy; 2016 Dec; 14(6):719-727. PubMed ID: 27581117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of highly purified menotropin versus recombinant follicle-stimulating hormone in in vitro fertilization/intracytoplasmic sperm injection cycles: a randomized, comparative trial.
    European and Israeli Study Group on Highly Purified Menotropin versus Recombinant Follicle-Stimulating Hormone
    Fertil Steril; 2002 Sep; 78(3):520-8. PubMed ID: 12215327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of human menopausal gonadotropin versus recombinant follicle-stimulating hormone for controlled ovarian hyperstimulation in assisted reproductive cycles: a meta-analysis.
    van Wely M; Westergaard LG; Bossuyt PM; van der Veen F
    Fertil Steril; 2003 Nov; 80(5):1086-93. PubMed ID: 14607553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
    Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highly purified hMG achieves better pregnancy rates in IVF cycles but not ICSI cycles compared with recombinant FSH: a meta-analysis.
    Al-Inany HG; Abou-Setta AM; Aboulghar MA; Mansour RT; Serour GI
    Gynecol Endocrinol; 2009 Jun; 25(6):372-8. PubMed ID: 19340668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinically relevant differences and "Biocreep".
    McDonough PG
    Fertil Steril; 2004 May; 81(5):1424-6. PubMed ID: 15136121
    [No Abstract]   [Full Text] [Related]  

  • 12. Cost-Effectiveness Analysis of the Gonadotropin Treatments HP-hMG and rFSH for Assisted Reproductive Technology in France: A Markov Model Analysis.
    Barriere P; Porcu-Buisson G; Hamamah S
    Appl Health Econ Health Policy; 2018 Feb; 16(1):65-77. PubMed ID: 29124676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of controlled ovarian stimulation with human menopausal gonadotropin or recombinant follicle-stimulating hormone.
    Filicori M; Cognigni GE; Pocognoli P; Tabarelli C; Ferlini F; Perri T; Parmegiani L
    Fertil Steril; 2003 Aug; 80(2):390-7. PubMed ID: 12909504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Health economic consequences of the choice of follicle stimulating hormone alternatives in IVF treatment].
    Poulsen PB; Højgaard A; Quartarolo JP
    Ugeskr Laeger; 2007 Apr; 169(14):1313-7. PubMed ID: 17437694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical efficacy of highly purified hMG versus recombinant FSH in IVF/ICSI cycles: a meta-analysis.
    Jee BC; Suh CS; Kim YB; Kim SH; Moon SY
    Gynecol Obstet Invest; 2010; 70(2):132-7. PubMed ID: 20389096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome from consecutive in-vitro fertilization/intracytoplasmic sperm injection attempts in the final group treated with urinary gonadotrophins and the first group treated with recombinant follicle stimulating hormone.
    Jacob S; Drudy L; Conroy R; Harrison RF
    Hum Reprod; 1998 Jul; 13(7):1783-7. PubMed ID: 9740423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinically relevant differences and "Biocreep".
    Auray JP; Duru G
    Fertil Steril; 2004 May; 81(5):1423; author reply 1423-4. PubMed ID: 15136119
    [No Abstract]   [Full Text] [Related]  

  • 18. Highly purified hMG versus recombinant FSH plus recombinant LH in intrauterine insemination cycles in women ≥35 years: a RCT.
    Moro F; Scarinci E; Palla C; Romani F; Familiari A; Tropea A; Leoncini E; Lanzone A; Apa R
    Hum Reprod; 2015 Jan; 30(1):179-85. PubMed ID: 25398971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corifollitropin alfa followed by highly purified HMG versus recombinant FSH in young poor ovarian responders: a multicentre randomized controlled clinical trial.
    Drakopoulos P; Vuong TNL; Ho NAV; Vaiarelli A; Ho MT; Blockeel C; Camus M; Lam AT; van de Vijver A; Humaidan P; Tournaye H; Polyzos NP
    Hum Reprod; 2017 Nov; 32(11):2225-2233. PubMed ID: 29040589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of human menopausal gonadotrophin and highly purified, urine-derived follicle stimulating hormone on the outcome of in-vitro fertilization in down-regulated normogonadotrophic women.
    Westergaard LG; Erb K; Laursen S; Rasmussen PE; Rex S
    Hum Reprod; 1996 Jun; 11(6):1209-13. PubMed ID: 8671425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.